EP 2629760 A4 20140402 - THERAPEUTIC NANOPARTICLES WITH HIGH MOLECULAR WEIGHT COPOLYMERS
Title (en)
THERAPEUTIC NANOPARTICLES WITH HIGH MOLECULAR WEIGHT COPOLYMERS
Title (de)
THERAPEUTISCHE NANOPARTIKEL MIT COPOLYMEREN VON HOHEM MOLEKULARGEWICHT
Title (fr)
NANOPARTICULES THÉRAPEUTIQUES CONTENANT DES COPOLYMÈRES DE MASSE MOLÉCULAIRE ÉLEVÉE
Publication
Application
Priority
- US 40577810 P 20101022
- US 201161490778 P 20110527
- US 2011057498 W 20111024
Abstract (en)
[origin: WO2012054923A2] The present disclosure generally relates to therapeutic nanoparticles. Exemplary nanoparticles disclosed herein may include about 0.1 to about 40 weight percent of a therapeutic agent and about 10 to about 90 weight percent a diblock poly(lactic) acid- poly(ethylene)glycol copolymer or a diblock poly(lactic)-co-poly(glycolic) acid- poly(ethylene)glycol copolymer, wherein the diblock poly(lactic) acid-poly(ethylene)glycol copolymer comprises poly(lactic) acid having a number average molecule weight of about 30 kDa to about 90 kDa or the diblock poly(lactic)-co-poly(glycolic) acid-poly(ethylene)glycol copolymer comprises poly(lactic)-co-poly(glycolic) acid having a number average molecule weight of about 30 kDa to about 90 kDa.
IPC 8 full level
A61K 31/573 (2006.01); A61K 9/127 (2006.01); A61K 9/22 (2006.01); A61K 31/56 (2006.01); A61K 33/243 (2019.01); A61K 47/30 (2006.01); A61K 47/48 (2006.01); A61K 33/24 (2019.01)
CPC (source: EP US)
A61K 9/0019 (2013.01 - EP US); A61K 9/5153 (2013.01 - EP US); A61K 31/196 (2013.01 - EP US); A61K 31/337 (2013.01 - EP US); A61K 31/365 (2013.01 - EP US); A61K 31/407 (2013.01 - EP US); A61K 31/4184 (2013.01 - EP US); A61K 31/4375 (2013.01 - EP US); A61K 31/555 (2013.01 - EP US); A61K 31/635 (2013.01 - EP US); A61K 33/24 (2013.01 - US); A61K 33/243 (2018.12 - EP US); A61K 38/05 (2013.01 - EP US); A61K 47/593 (2017.07 - EP US); A61K 47/60 (2017.07 - EP US); A61P 29/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61K 33/24 (2013.01 - EP)
Citation (search report)
- [X] WO 2010005721 A2 20100114 - BIND BIOSCIENCES INC [US], et al
- [I] WO 2010005725 A2 20100114 - BIND BIOSCIENCES INC [US], et al
- [A] WO 2007074604 A1 20070705 - LTT BIO PHARMA CO LTD [JP], et al
- [A] WO 03017987 A1 20030306 - UNIV MCGILL [CA], et al
- [A] MATSUMOTO J ET AL: "Preparation of nanoparticles consisted of poly (L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL, vol. 185, 2 January 1999 (1999-01-02), pages 93 - 101, XP003014177, ISSN: 0378-5173, DOI: 10.1016/S0378-5173(99)00153-2
- [A] VERRECCHIA T ET AL: "Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 36, no. 1, 1 September 1995 (1995-09-01), pages 49 - 61, XP004037468, ISSN: 0168-3659, DOI: 10.1016/0168-3659(95)00053-B
- See references of WO 2012054923A2
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2012054923 A2 20120426; WO 2012054923 A3 20120705; EA 201390600 A1 20130930; EP 2629760 A2 20130828; EP 2629760 A4 20140402; JP 2013543844 A 20131209; US 2015056300 A1 20150226; US 2018000885 A1 20180104
DOCDB simple family (application)
US 2011057498 W 20111024; EA 201390600 A 20111024; EP 11835279 A 20111024; JP 2013535141 A 20111024; US 201113880853 A 20111024; US 201715623533 A 20170615